Skip to main content
Caplight Logo









Elo Life Systems

Elo Life Systems

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://elolife.com/

Last Round

Series A

Extension

Jan 24, 2024

Total Funding Raised

$45M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Elo Life Systems is a biotechnology company that specializes in precision gene editing to create sustainable, healthier food alternatives by utilizing advanced breeding technologies, genomics, and data analytics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

molecular farmingsweet proteinsprecision breedingplant-based sweetenersfood techagtechzero-calorie sweetenersfunctional ingredientscrop improvementcomputational biologysynthetic biologyalternative sweetenerstrait developmentbiotechsugar alternatives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elo Life Systems Comparables

Compare Elo Life Systems with similar companies based on industry and business-model similarity.

Elo Life Systems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Amai Proteins
84%
Oobli
82%
Naturannova
80%

Elo Life Systems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 24, 2024
Series AFeb 15, 2023

Key People

Founding team and executive leadership

Todd Rands

President and CEO

Executive Team

Michele Fite

Fractional Chief Commercial Officer (CCO)

Executive Team

Elo Life Systems Investors

Notable investors and investment history

Elo Life Systems investors
InvestorRounds
DCVC BioSeries A Extension, Series A
Accelr8 Technology CorporationSeries A Extension, Series A
Hanwha Asset ManagementSeries A Extension
Hanwha Asset ManagementSeries A Extension
Novo HoldingsSeries A Extension, Series A
Alexandria Venture InvestmentsSeries A Extension
DCVC (Data Collective)Series A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 76% MoM, reaching 4.1K.

  • Feb 15, 2023

    $25M round led by Novo Holdings and DCVC

Elo Life Systems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elo Life Systems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elo Life Systems's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range25
Year Founded2021
Last FundingJan 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?